GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/7/2026 5:15:39 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $35,000,000 | Assets $40,157,000 | EPS $0.89 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/8/2026 5:15:47 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $45,438,000 | EPS -$0.18 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/30/2026 5:56:45 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $90,000 | Assets $51,775,000 | EPS -$1.09 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/14/2025 5:02:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $90,000 | Assets $56,151,000 | EPS -$0.16 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/5/2025 5:03:44 PM | View | Proxy | SEC | Y 2024 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/8/2025 5:13:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $63,017,000 | EPS -$0.22 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/9/2025 5:36:54 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $68,647,000 | EPS -$0.51 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/31/2025 5:13:26 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $76,899,000 | EPS -$1.27 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/14/2024 5:11:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $82,114,000 | EPS -$0.37 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/5/2024 5:02:07 PM | View | Proxy | SEC | Y 2023 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/5/2024 5:29:31 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $89,861,000 | EPS -$0.38 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 4/26/2024 5:16:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $927,000 +69.5% | Assets $88,352,000 | EPS -$0.31 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/29/2024 5:07:35 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $81,000 -92.1% | Assets $81,445,000 | EPS -$1.83 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/9/2023 5:06:12 PM | View | Proxy | SEC | Y 2022 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/2/2023 9:16:33 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $1,075,000 +2,288.9% | Assets $88,944,000 | EPS -$0.49 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/14/2023 5:17:04 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $99,051,000 | EPS -$0.58 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/15/2023 5:10:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $547,000 -41.8% | Assets $102,026,000 | EPS -$0.43 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/31/2023 5:09:33 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $1,030,000 -10.0% | Assets $114,192,000 | EPS -$1.37 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/21/2022 5:02:07 PM | View | Proxy | SEC | Y 2021 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/14/2022 5:14:46 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $45,000 -80.7% | Assets $116,816,000 | EPS -$0.38 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/12/2022 5:16:17 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $45,000 -83.1% | Assets $121,800,000 | EPS -$0.33 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/13/2022 5:22:20 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $940,000 +51.1% | Assets $74,562,000 | EPS -$0.23 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/25/2022 5:23:32 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $1,144,000 +542.7% | Assets $80,388,000 | EPS -$1.20 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/12/2021 5:23:14 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $233,000 +219.2% | Assets $84,479,000 | EPS -$0.30 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 10/18/2021 5:19:29 PM | View | Proxy | SEC | Y 2020 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 7/30/2021 5:11:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $266,000 +618.9% | Assets $84,454,000 | EPS -$0.25 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/14/2021 5:14:43 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $622,000 +4,684.6% | Assets $75,097,000 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/31/2021 5:15:27 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $178,000 +3.5% | Assets $66,397,000 | EPS -$1.83 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 10/23/2020 5:13:01 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $73,000 +37.7% | Assets $50,527,000 | EPS -$0.36 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 10/7/2020 5:01:24 PM | View | Proxy | SEC | Y 2019 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/14/2020 5:25:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $37,000 -37.3% | Assets $55,958,000 | EPS -$0.41 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 6/30/2020 6:44:26 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $13,000 -55.2% | Assets $8,364,000 | EPS -$0.98 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/8/2020 5:12:01 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $172,000 -0.8% | Assets $11,670,000 | EPS -$4.40 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/25/2019 5:22:04 PM | View | Proxy | SEC | Y 2018 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/12/2019 5:05:28 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $53,000 +7.8% | Assets $16,317,781 | EPS -$1.21 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/9/2019 5:19:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $59,000 +17.9% | Assets $21,818,881 | EPS -$1.00 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/10/2019 5:09:23 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $29,000 -4.4% | Assets $12,235,010 | EPS -$0.05 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/19/2019 5:08:54 PM | View | Financials | Earnings | WIRE | Y 2018 | Rev $43,810 +706.8% | Assets $14,889,394 | EPS -$0.05 | Export Earnings Model | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/15/2019 5:12:00 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $173,359 +3,092.6% | Assets $14,889,394 | EPS -$0.22 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/16/2018 5:01:54 PM | View | Proxy | SEC | Y 2017 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/9/2018 5:15:31 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $49,177 | Assets $15,702,316 | EPS -$0.06 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/9/2018 5:11:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $50,030 | Assets $22,584,512 | EPS -$0.04 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/10/2018 4:55:06 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $30,342 | Assets $28,140,652 | EPS -$0.07 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/16/2018 5:17:03 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $5,430 | Assets $18,337,107 | EPS -$0.40 | |
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/14/2017 4:50:36 PM | View | Proxy | SEC | Y 2016 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/3/2017 4:44:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $21,721,366 | EPS -$0.09 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/4/2017 4:27:03 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $12,976,587 | EPS -$0.12 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/15/2017 2:05:40 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $18,244,889 | EPS -$0.14 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/16/2017 4:29:57 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $22,528,886 | EPS -$0.50 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/18/2016 4:34:22 PM | View | Proxy | SEC | Y 2015 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 10/28/2016 5:01:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $17,261,840 | EPS -$0.14 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 7/29/2016 4:46:25 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $21,572,559 | EPS -$0.15 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/10/2016 4:27:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $23,344,199 | EPS -$0.10 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/11/2016 5:08:13 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $26,587,581 | EPS -$0.55 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/12/2015 4:47:31 PM | View | Proxy | SEC | Y 2014 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 10/30/2015 4:16:13 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $25,049,707 | EPS -$0.10 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/7/2015 4:43:14 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $26,330,461 | EPS -$0.20 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/3/2015 8:06:16 AM | View | Financials | Earnings | SEC | 2Q 2015 | Assets $26,330,461 | EPS -$0.20 | Export Earnings Model | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/8/2015 4:06:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $20,055,128 | EPS -$0.09 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 3/16/2015 4:12:57 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Assets $7,569,086 | EPS -$0.90 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/14/2014 4:11:47 PM | View | Proxy | SEC | Y 2013 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 10/31/2014 3:45:40 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Assets $12,598,322 | EPS -$0.21 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/12/2014 4:45:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Assets $15,446,553 | EPS $0.10 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/12/2014 4:53:46 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Assets $6,559,906 | EPS -$0.66 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 2/28/2014 3:37:12 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Assets $5,765,675 | EPS -$0.47 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/26/2013 3:37:04 PM | View | Proxy | SEC | Y 2012 | ||||||
| Actinium Pharmaceuticals, Inc. (ATNM) | 11/14/2013 10:35:19 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Assets $4,049,981 | EPS -$0.06 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 8/13/2013 5:10:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Assets $5,734,598 | EPS -$0.13 | ||
| Actinium Pharmaceuticals, Inc. (ATNM) | 5/15/2013 4:09:32 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Assets $3,357,029 | EPS -$0.03 | ||
| Cactus Ventures, Inc. (ATNM) | 3/29/2013 1:45:44 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Assets $5,788,822 | EPS -$7.58 | ||
| Cactus Ventures, Inc. (ATNM) | 1/29/2013 1:36:21 PM | View | Proxy | SEC | Y 2012 | ||||||
| Cactus Ventures, Inc. (ATNM) | 11/14/2012 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | EPS -$3.76 | |||
| Cactus Ventures, Inc. (ATNM) | 8/29/2012 2:54:42 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2012 ending: 6/30/2012 | Assets $142 | EPS -$0.09 | ||
| Cactus Ventures, Inc. (ATNM) | 4/23/2012 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | ||||
| Cactus Ventures, Inc. (ATNM) | 4/12/2012 2:45:29 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Assets $6,200,497 | EPS -$4.30 | ||
| Cactus Ventures, Inc. (ATNM) | 11/14/2011 11:38:02 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | ||||
| Cactus Ventures, Inc. (ATNM) | 8/12/2011 2:51:39 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 |